TARA
Protara Therapeutics, Inc. - Common Stock (TARA)
$51
About Protara Therapeutics, Inc. - Common Stock (TARA)
Protara Therapeutics, Inc. is a clinical-stage company engaged in developing treatments for rare and specialty diseases with significant unmet needs. Its current development programs focus on the treatment of rare diseases in structural and connective tissues and rare hepatology, gastrointestinal, and metabolic disorders. The company was founded by Jesse Shefferman and Jacqueline Zummo in March 2006 and is headquartered in New York, NY.
Details
Daily high
$3.65
Daily low
$3.47
Price at open
$3.59
52 Week High
$7.82
52 Week Low
$3.45
Market cap
209.8M
Dividend yield
-
Volume
734,589
Avg. volume
705,138
P/E ratio
-2.62
Protara Therapeutics, Inc. - Common Stock News
Details
Daily high
$3.65
Daily low
$3.47
Price at open
$3.59
52 Week High
$7.82
52 Week Low
$3.45
Market cap
209.8M
Dividend yield
-
Volume
734,589
Avg. volume
705,138
P/E ratio
-2.62